vs

Side-by-side financial comparison of QT IMAGING HOLDINGS, INC. (QTI) and SOLESENCE, INC. (SLSN). Click either name above to swap in a different company.

SOLESENCE, INC. is the larger business by last-quarter revenue ($12.5M vs $8.3M, roughly 1.5× QT IMAGING HOLDINGS, INC.). SOLESENCE, INC. runs the higher net margin — 1.3% vs -16.8%, a 18.1% gap on every dollar of revenue. On growth, QT IMAGING HOLDINGS, INC. posted the faster year-over-year revenue change (877.2% vs -0.7%).

QT Imaging Holdings, Inc. is a medical technology company that designs, manufactures and commercializes non-invasive medical imaging systems primarily for breast health diagnostics. It serves healthcare providers, clinics and medical institutions across key markets including North America, Europe and Asia-Pacific, focusing on improving the accuracy and accessibility of diagnostic imaging for patients.

QTI vs SLSN — Head-to-Head

Bigger by revenue
SLSN
SLSN
1.5× larger
SLSN
$12.5M
$8.3M
QTI
Growing faster (revenue YoY)
QTI
QTI
+877.8% gap
QTI
877.2%
-0.7%
SLSN
Higher net margin
SLSN
SLSN
18.1% more per $
SLSN
1.3%
-16.8%
QTI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
QTI
QTI
SLSN
SLSN
Revenue
$8.3M
$12.5M
Net Profit
$-1.4M
$163.0K
Gross Margin
38.0%
27.5%
Operating Margin
-8.5%
1.5%
Net Margin
-16.8%
1.3%
Revenue YoY
877.2%
-0.7%
Net Profit YoY
60.2%
129.2%
EPS (diluted)
$-1.00
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
QTI
QTI
SLSN
SLSN
Q4 25
$8.3M
$12.5M
Q3 25
$4.2M
$14.6M
Q2 25
$3.7M
$20.4M
Q1 25
$2.8M
$14.6M
Q4 24
$12.6M
Q3 24
$16.9M
Q2 24
$1.7M
$13.0M
Q1 24
$1.4M
$9.9M
Net Profit
QTI
QTI
SLSN
SLSN
Q4 25
$-1.4M
$163.0K
Q3 25
$-4.6M
$-1.1M
Q2 25
$-4.0M
$2.7M
Q1 25
$-11.1M
$80.0K
Q4 24
$-559.0K
Q3 24
$3.0M
Q2 24
$-1.2M
$856.0K
Q1 24
$-628.6K
$893.0K
Gross Margin
QTI
QTI
SLSN
SLSN
Q4 25
38.0%
27.5%
Q3 25
43.0%
23.1%
Q2 25
49.9%
28.9%
Q1 25
64.7%
23.1%
Q4 24
22.0%
Q3 24
36.2%
Q2 24
51.0%
28.7%
Q1 24
55.8%
36.3%
Operating Margin
QTI
QTI
SLSN
SLSN
Q4 25
-8.5%
1.5%
Q3 25
-39.4%
-5.4%
Q2 25
-28.5%
9.4%
Q1 25
-37.2%
1.8%
Q4 24
-1.8%
Q3 24
19.0%
Q2 24
-129.5%
8.0%
Q1 24
-409.5%
11.3%
Net Margin
QTI
QTI
SLSN
SLSN
Q4 25
-16.8%
1.3%
Q3 25
-108.7%
-7.7%
Q2 25
-109.3%
13.1%
Q1 25
-397.9%
0.5%
Q4 24
-4.4%
Q3 24
18.1%
Q2 24
-72.9%
6.6%
Q1 24
-46.1%
9.0%
EPS (diluted)
QTI
QTI
SLSN
SLSN
Q4 25
$-1.00
$0.00
Q3 25
$-0.47
$-0.02
Q2 25
$-0.14
$0.04
Q1 25
$-0.40
$0.00
Q4 24
$0.00
Q3 24
$0.04
Q2 24
$-0.30
$0.01
Q1 24
$-0.05
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
QTI
QTI
SLSN
SLSN
Cash + ST InvestmentsLiquidity on hand
$10.4M
$1.3M
Total DebtLower is stronger
$10.1M
Stockholders' EquityBook value
$6.4M
$17.6M
Total Assets
$23.0M
$50.1M
Debt / EquityLower = less leverage
1.57×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
QTI
QTI
SLSN
SLSN
Q4 25
$10.4M
$1.3M
Q3 25
$429.0K
Q2 25
$4.1M
Q1 25
$1.8M
Q4 24
$1.4M
Q3 24
$2.9M
Q2 24
$2.4M
Q1 24
$2.0M
Total Debt
QTI
QTI
SLSN
SLSN
Q4 25
$10.1M
Q3 25
$15.1M
Q2 25
$10.1M
Q1 25
$10.2M
Q4 24
Q3 24
Q2 24
$11.7M
Q1 24
$11.7M
Stockholders' Equity
QTI
QTI
SLSN
SLSN
Q4 25
$6.4M
$17.6M
Q3 25
$-9.1M
$17.2M
Q2 25
$-324.3K
$18.2M
Q1 25
$-20.2M
$15.2M
Q4 24
$14.9M
Q3 24
$15.2M
Q2 24
$-6.2M
$11.9M
Q1 24
$-4.9M
$5.0M
Total Assets
QTI
QTI
SLSN
SLSN
Q4 25
$23.0M
$50.1M
Q3 25
$12.1M
$54.0M
Q2 25
$11.6M
$60.0M
Q1 25
$10.9M
$57.0M
Q4 24
$50.0M
Q3 24
$48.0M
Q2 24
$10.8M
$40.8M
Q1 24
$12.9M
$38.5M
Debt / Equity
QTI
QTI
SLSN
SLSN
Q4 25
1.57×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
QTI
QTI
SLSN
SLSN
Operating Cash FlowLast quarter
$-3.1M
$1.8M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
11.16×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
QTI
QTI
SLSN
SLSN
Q4 25
$-3.1M
$1.8M
Q3 25
$-878.8K
$-2.5M
Q2 25
$-1.4M
$-654.0K
Q1 25
$-3.5M
$-7.2M
Q4 24
$2.2M
Q3 24
$4.2M
Q2 24
$-979.6K
$-565.0K
Q1 24
$-6.0M
$-3.9M
Free Cash Flow
QTI
QTI
SLSN
SLSN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$-404.0K
Q3 24
$2.8M
Q2 24
$-1.0M
Q1 24
$-3.9M
FCF Margin
QTI
QTI
SLSN
SLSN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-3.2%
Q3 24
16.6%
Q2 24
-8.0%
Q1 24
-39.9%
Capex Intensity
QTI
QTI
SLSN
SLSN
Q4 25
Q3 25
0.0%
Q2 25
Q1 25
Q4 24
20.6%
Q3 24
8.3%
Q2 24
3.7%
Q1 24
0.9%
Cash Conversion
QTI
QTI
SLSN
SLSN
Q4 25
11.16×
Q3 25
Q2 25
-0.25×
Q1 25
-90.26×
Q4 24
Q3 24
1.38×
Q2 24
-0.66×
Q1 24
-4.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons